...
首页> 外文期刊>Journal of Huazhong University of Science and Technology >Application of Fetal DNA in Maternal Plasma in Noninvasive Prenatal Diagnosis
【24h】

Application of Fetal DNA in Maternal Plasma in Noninvasive Prenatal Diagnosis

机译:胎儿DNA在母体血浆中的无创产前诊断中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

To explore the application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis, the DNA template was extracted by hydroxybenzene-chloroform from 44 maternal (7-41 weeks) plasma. The Fetus-derived Y sequence DYZ-1 gene (149bp) was chosen to be amplified by PCR. The fragment was identified in all the plasma of male bearing pregnant women with the diagnostic accordance rate being 100.00%. Two of the 22 female bearing pregnant women had false positive results. Among the 44 pregnant women, the diagnostic accordance rate was 88.89% at early pregnant stage, 100.00% at medium pregnant stage, and 96.55% at late stage respectively. The final accuracy of 95.45% was obtained in all cases. It was concluded that by means of hydroxybenzene-chloroform extraction the authors of this article promoted the concentration and purity of the DNA template, and diagnosed more accurately. The results showed that free fetal DNA in the maternal plasma could be regarded as the gene resource for noninvasive prenatal diagnosis.
机译:为了探索胎儿DNA在母体血浆中用于无创产前诊断的目的,通过羟苯-氯仿从44个母体(7-41周)血浆中提取了DNA模板。选择胎儿来源的Y序列DYZ-1基因(149bp)进行PCR扩增。在所有男性孕妇的血浆中均鉴​​定出该片段,诊断符合率为100.00%。 22名女性孕妇中有2名有假阳性结果。在这44名孕妇中,妊娠早期诊断符合率为88.89%,中期妊娠为100.00%,晚期诊断为96.55%。在所有情况下,最终精度均为95.45%。结论是,通过羟苯-氯仿提取提高了DNA模板的浓度和纯度,并进行了更准确的诊断。结果表明,母体血浆中游离胎儿DNA可被视为无创产前诊断的基因资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号